2022
DOI: 10.1080/10406638.2022.2069133
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Biological Evaluation, and Molecular Docking of New Benzimidazole-1,2,3-Triazole Hybrids as Antibacterial and Antitumor Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 44 publications
0
7
0
Order By: Relevance
“…The ligand efficiency was performed for further validation for docking protocol. The ligand efficiency values were within the acceptable range, indicating a reliable docking procedure [51,52] …”
Section: Resultsmentioning
confidence: 70%
See 1 more Smart Citation
“…The ligand efficiency was performed for further validation for docking protocol. The ligand efficiency values were within the acceptable range, indicating a reliable docking procedure [51,52] …”
Section: Resultsmentioning
confidence: 70%
“…The ligand efficiency values were within the acceptable range, indicating a reliable docking procedure. [51,52]…”
Section: Molecular Docking Analysismentioning
confidence: 99%
“…Compound 15 a (Figure 21 ) , demonstrated the most promising results with an IC 50 value of 3.23, 6.56, and 5.35 μM against the MCF‐7, HepG2, and HCT‐116 cell lines respectively. The molecular docking study also supported most potent compounds 15 a with interaction similar to erlotinib with EGFR protein [79] …”
Section: Recent Development Of Different Nitrogen Containing Derivati...mentioning
confidence: 62%
“…The molecular docking study also supported most potent compounds 15 a with interaction similar to erlotinib with EGFR protein. [79] A study on the design and synthesis of 1,3,4-triazole compounds as EGFR inhibitors were reported by Kumar et al, in the year 2022. In a cytotoxicity assay, it was discovered that synthetic compounds 16 a and 16 b (Figure 22) were superior to doxorubicin and erlotinib against MCF-7 and HeLa cell lines.…”
Section: Triazolementioning
confidence: 99%
“…To verify the relationship between the biological findings in vitro and the interaction affinities of the investigated hybrids, the docking analysis of the most active derivatives, 2 , 4 and 6 , was assessed to identify their binding mode inside the (PDB: 1DLS) [ 40 ] and DNA gyrase (PDB; 4uro [ 41 , 42 , 43 ]) active sites, as well as the structural orientation and conformation. The docking steps were applied as in a previously reported method [ 44 , 45 ]. The 3D loop of dihydrofolate-reductase “DHFR” was created using the mGenTHERADER, which utilized the docking framework.…”
Section: Resultsmentioning
confidence: 99%